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Background: We investigated the associations between vitamin D status in early and late pregnancy with neonatal
small for gestational age (SGA), low birth weight (LBW) and preterm delivery. Furthermore, associations between
vitamin D status and pregnancy loss were studied.
Methods: Serum 25-hydroxyvitamin D (25OHD) was sampled in gestational week ≤ 16 (trimester 1 (T1), N = 2046)
and > 31 (trimester 3 (T3), N = 1816) and analysed using liquid chromatography tandem mass spectrometry. Pregnant
women were recruited at antenatal clinics in south-west Sweden at latitude 57–58°N. Gestational and neonatal data
were retrieved from medical records. Multiple gestations and terminated pregnancies were excluded from the analyses.
SGA was defined as weight and/or length at birth < 2 SD of the population mean and LBW as < 2500 g. Preterm
delivery was defined as delivery < 37 + 0 gestational weeks and pregnancy loss as spontaneous abortion or
intrauterine fetal death. Associations between neonatal outcomes and 25OHD at T1, T3 and change in 25OHD
(T3-T1) were studied using logistic regression.
Results: T1 25OHD was negatively associated with pregnancy loss and 1 nmol/L increase in 25OHD was associated
with 1% lower odds of pregnancy loss (OR 0.99, p = 0.046). T3 25OHD ≥ 100 nmol/L (equal to 40 ng/ml) was associated
with lower odds of SGA (OR 0.3, p = 0.031) and LBW (OR 0.2, p = 0.046), compared to vitamin D deficiency
(25OHD < 30 nmol/L, or 12 ng/ml). Women with a≥ 30 nmol/L increment in 25OHD from T1 to T3 had the lowest
odds of SGA, LBW and preterm delivery.
Conclusions: Vitamin D deficiency in late pregnancy was associated with higher odds of SGA and LBW. Lower 25OHD
in early pregnancy was only associated with pregnancy loss. Vitamin D status trajectory from early to late pregnancy
was inversely associated with SGA, LBW and preterm delivery with the lowest odds among women with the highest
increment in 25OHD. Thus, both higher vitamin D status in late pregnancy and gestational vitamin D status trajectory
can be suspected to play a role in healthy pregnancy.
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Placental pathology is often found in pregnancies compli-
cated by intrauterine growth restriction, preeclampsia or
intrauterine fetal death. It is associated with inadequate
invasion of extravillous trophoblasts and inadequate
angiogenesis, with insufficient conversion of arterial spiral
arteries in the decidua [1]. These processes are complex
and normal development is dependent on several factors.
Vitamin D status (measured as 25-hydroxyvitamin D
(25OHD)) of pregnant women has been inversely associ-
ated with adverse gestational outcomes and associated with
uteroplacental dysfunction [2].
We have previously shown that higher vitamin D sta-
tus in late pregnancy and larger increase in vitamin D
status during pregnancy is associated with lower risk of
preeclampsia [3]. Associations have also been shown
between vitamin D insufficiency (< 50 nmol/L) and
increased risk of infant small for gestational age (SGA)
and low birth weight (LBW) [4]. Circulating concentra-
tions of 25OHD below 25 or 30 nmol/L have been asso-
ciated with 50–300% increased odds of SGA, compared
to higher concentrations [5–7]. Also, maternal 25OHD
< 28 nmol/L in late, but not early, pregnancy have been
associated with lower infant birth size and shorter
gestational length in a smaller longitudinal study [8].
However, there is also limited evidence for a U-shaped as-
sociation where high 25OHD concentrations (> 80 nmol/
L) may be related to higher risk of SGA [9]. Thus, the as-
sociation between vitamin D status and neonatal birth size
is not clear and warrants further investigation. A recent
meta-analysis of 10 studies concluded that 25OHD
concentrations < 50 nmol/L were associated with an
approximately 30% increased risk of preterm delivery [10].
Bodnar et al. found that early pregnancy 25OHD concen-
trations < 75 nmol/L were associated with higher risk of
both medically indicated and spontaneous preterm deliv-
ery [11]. Lower vitamin D status has also been associated
with a medical history of recurrent miscarriage [12] but
only two prospective studies have investigated this, with-
out finding that lower 25OHD concentrations increases
the risk of pregnancy loss [5, 13]. Both these prospective
studies had relatively few cases of pregnancy loss and may
therefore have been insufficiently powered to study this
association. Thus, the association between vitamin D
status and risk of miscarriage needs further investigation.
To our knowledge, no previous study has related
25OHD concentration in both early and late pregnancy to
neonatal outcomes related to placental dysfunction.
Therefore, it has not been possible to ascertain whether
the associations at implantation in early pregnancy differ
from those during the fetal growth spurt in late pregnancy.
Our objectives were to study the associations between
vitamin D status in both early and late pregnancy, as
well as change in vitamin D status during pregnancywith neonatal SGA, LBW and preterm delivery. Associa-
tions between vitamin D status in early pregnancy and
pregnancy loss were also studied.
Methods
The GraviD study is a prospective cohort study, con-
ducted in parts of the Västra Götaland region in the
southwest of Sweden, at latitude 57–58°N [3]. Pregnant
women were recruited from gestational week 4 during
fall 2013 and spring 2014, when registering at one of the
participating antenatal care units. The only exclusion
criterion was pregnancy exceeding 16 gestational weeks
at inclusion. Gestational age at delivery and data collec-
tion was determined by routine ultrasound in the second
trimester, but gestational age at inclusion was based on
the date of the last menstrual period. Women who ter-
minated the pregnancy (N = 31), were lost to follow-up
(N = 13) or carried more than one foetus (N = 26) were
excluded from the present analyses. Pregnancy termin-
ation was mostly due to fetal malformations. Women
who were lost to follow-up had moved and their medical
records could not be retrieved. This study was
conducted according to the Declaration of Helsinki and
all procedures were approved by the Regional Ethics
Committee in Gothenburg, Sweden. Written informed
consent was obtained from all participants.
Outcomes
SGA was defined as either weight or length at birth
below 2 SD of the gender-specific population mean [14].
LBW was defined as weight at birth < 2500 g. Preterm
delivery was defined as delivery before gestational week
+days 37 + 0, including both induced and spontaneous
preterm delivery. Pregnancy loss was defined as both
spontaneous abortions from gestational week 4 and intra-
uterine fetal death (IUFD). Late pregnancy loss was
defined as spontaneous abortion at gestational week ≥ 14
+ 0, including IUFD. IUFD was defined as pregnancy loss
at gestational week ≥ 22 + 0. Pregnancy loss before gesta-
tional week 22 was based on self-report data and medical
records to verify miscarriage were not available. Informa-
tion on IUFD was collected from medical records from
the obstetrics care.
Exposure
Maternal blood samples were collected from each partici-
pant at two time points; before gestational week 16
(predominantly week 8–12, first trimester, T1) and after
gestational week 31 (predominantly week 32–35, third tri-
mester, T3). Non-fasting venous blood samples were drawn
in gel serum separating tubes and centrifuged for 10 min
within 2 h of sampling. Serum was stored at − 70 °C until
analysis of 25OHD. Analyses were performed by liquid
chromatography tandem mass spectrometry (LC-MS/MS,
Fig. 1 Flow chart of the study inclusion
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boratory in Region Skåne, Sweden, certified by the Vitamin
D External Quality Assessment Scheme [15]. The LC-MS/
MS method has a measuring range of 6–450 nmol/L for
25OHD3 and of 6–225 nmol/L for 25OHD2. The inter-
assay coefficient of variation is 6% at 40 nmol/L for both
25OHD3 and 25OHD2. Sampling and laboratory analyses
have been described previously [3]. Maternal serum T1
and T3 samples were analysed in sequence. At T1 and T3,
participants answered questionnaires regarding lifestyle
factors and background data. Neonatal and gestational data
were obtained from antenatal and obstetrics medical re-
cords. Information on BMI at T1 and season of conception
(December–May or June–November) was obtained from
the medical records. Season was coded as a binary variable,
since this explained 30% of vitamin D status in a previous
study in pregnant women at the same latitude [16]. Data
on education level (≤primary level, secondary level or uni-
versity level) and origin (continent of birth: Northern Eur-
ope, Continental Europe, America, Asia, Africa) were
collected from study questionnaires.
Statistical analysis
Concentrations of 25OHD at T1 and T3 were used as
categorical variables, grouped into 25OHD < 30 (used as
reference category), 30–49.9, 50–74.9, 75–99.9 and ≥
100 nmol/L. These groups were chosen to study whether
vitamin D insufficiency (30–50 nmol/L), sufficiency (≥
50 nmol/L) or high status (≥ 75 or ≥ 100 nmol/L) was asso-
ciated with the outcomes studied, compared to vitamin D
deficiency (< 30 nmol/L). Quartiles were not used because
the distribution of 25OHD was different at T1 and T3. T1
25OHD was also investigated as a continuous variable as
there were few cases in some categories. Change in
25OHD was calculated as the difference between T3 and
T1 (T3-T1) and was coded into 3 groups: decrease in
25OHD (≤ 0 nmol/L), small increase (0.1–29.99 nmol/L)
or large increase (≥30 nmol/L).
Multivariable logistic regression analyses of the outcome
variables SGA, LBW and preterm delivery were performed
with 25OHD at T1, T3 and change in 25OHD during
pregnancy as the independent variables. For SGA, appro-
priate for gestational age and large for gestational age were
combined as reference. Potential confounders for the as-
sociations studied were identified using directed acyclic
graphs (www.dagitty.net) [17]. Variables BMI, season of
conception, education level and origin were identified and
included in the final models. Tobacco use and vitamin D
supplement use were also investigated as potential
confounders but did not show any confounding effect and
were thus not included in the final models. In the multi-
variable analysis with change in 25OHD as the independ-
ent variable, T1 25OHD was also included as a
confounder. Correlation between continuous T1 25OHDand continuous change in 25OHD was low (r = − 0.22, p
< 0.001) and it was therefore considered acceptable to
include both variables in the same model. Multivariable
logistic regression analysis of the outcome pregnancy loss
was also performed with 25OHD at T1 (continuous and
categorical) as independent variable. These models were
adjusted for BMI, season of conception, education level,
origin and gestational age at registration to antenatal care
(based on last menstrual period). Unadjusted logistic
regression analysis was used to assess the association
between T1 25OHD (< 30 nmol/L; no/yes) and IUFD.
Here, no confounders were included due to the small
number of cases (N = 9). Significance was accepted at
p < 0.05. Computer software IBM SPSS Statistics version
22.0 was used for all statistical analyses.
Results
In total, 2052 women were included in this study, 2046
with a blood sample at T1 and 1816 at T3 (Fig. 1). In
total, 1810 women had samples collected both in T1 and
T3. Characteristics of the women and the live born
infants are shown in Table 1. Mean infant birth weight
was 3542 (538) grams and mean gestational age at deliv-
ery was 280 (12.4) days. Mean (SD) maternal 25OHD at
T1 was 64 (24.4) nmol/L and 75 (34.4) nmol/L at T3. At
T1, 10% had 25OHD concentrations < 30 nmol/L and
9% at T3 (Table 2).
Birth size and preterm delivery
In total, 93 (4.5%) infants were born SGA. Of the SGA
deliveries, 37 were SGA by weight and 56 by length.
Also, 58 (2.8%) infants had LBW, while 78 (3.8%) infants
were delivered preterm (Table 1). Of those who delivered
preterm, 10 delivered before gestational week 31 and
thus before the T3 blood sample could be drawn.
Table 1 Characteristics of the pregnant women and their
infants at birth
Mean SD
Birth weight (grams)a 3542 537.7
Birth length (cm)a 50 2.3
Gestational age at delivery (days) 280 12.4
Gestational age T1 (days) 76 13.8
Gestational age T3 (days) 234 12.9
Maternal s-25OHD T1 (nmol/L) 64 24.4
Maternal s-25OHD T3 (nmol/L) 75 34.4
N (%)
Male gender of infanta 976 (49.8)
Small for gestational age (weight or length) 93 (4.5)
Low birth weight (< 2500 g) 58 (2.8)
Preterm delivery (< 37 weeks) 78 (3.8)
Spontaneous preterm delivery (< 37 weeks) 55 (2.7)
Pregnancy loss 97 (4.7)
Intrauterine fetal death (≥ 22 weeks) 9 (0.5)
T1 first trimester, T3 third trimester, 25OHD 25-hydroxyvitamin D
aLive born infants only
Table 2 The pregnant women’s vitamin D status in the first (T1) an
(mean or percent) grouped by 25OHD concentration in (T1)
T1 25OHD (nmol/L) < 30 30–49
N 198 291
% 10.1 14.8
BMI T1 (kg/m2) 25.1 24.9
Age T1 (years) 29.4 30.9
Born in Sweden (%) 14.1 54.6
Tobacco use T1 (%) 6.8 4.6
Nulliparous T1 (%) 34.8 42.0
Vitamin D supplement use T1 (%) 10.6 28.2
University level education (%) 32.3 54.9
Small for gestational age (%) 5.7 4.2
Preterm delivery (%) 4.1 5.2
Low birth weight (%) 3.0 4.5
Pregnancy loss (%) 6.3 5.6
T3 25OHD (nmol/L) < 30 30–49
N 163 330
% 9.0 18.2
Small for gestational age (%) 7.5 5.5
Preterm delivery (%) 4.3 1.2
Low birth weight (%) 4.3 0.3
T1 first trimester, T3 third trimester, 25OHD 25-hydroxyvitamin D
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tion < 30 nmol/L in T1.
There were no associations between the predictor T1
25OHD and the outcomes SGA, LBW and preterm delivery
(Table 3). Women with T3 25OHD ≥ 100 nmol/L had a
lower OR for SGA (OR= 0.32, p = 0.031) compared to those
with vitamin D deficiency (< 30 nmol/L). Women with T3
25OHD concentrations ≥ 100 nmol/L and 30–50 nmol/L
had lower OR for LBW (OR= 0.22, p = 0.046 and OR=
0.07, p = 0.017, respectively), compared to vitamin D
deficiency. However, T3 25OHD was not significantly
associated with preterm delivery. The results were not
meaningfully affected by additional adjustment for tobacco
use or vitamin D supplementation or by excluding cases of
preeclampsia (data not shown).
Vitamin D status trajectory between T1 and T3 was
inversely related to SGA, preterm and LBW (Table 3).
Compared to women with a large increase in 25OHD
(≥30 nmol/L), women with a decrease in 25OHD had
significantly higher OR of having a child born SGA (OR
= 3.7, p = 0.002), with LBW (OR = 4.7, p = 0.014) as well
as a trend toward higher odds of preterm delivery (OR =
2.9, p = 0.061). Women with a small increase in 25OHD
(0–30 nmol/L) had significantly higher OR of SGA (OR
= 2.6, p = 0.019) and preterm delivery (OR = 2.9, p =
0.047) as well as a trend toward significance for LBWd third (T3) trimester of pregnancy, and their characteristics
.9 50–74.9 75–99.9 ≥ 100
788 565 125
40.1 28.7 6.4
24.4 23.9 24.4
31.6 32.0 32.4
83.3 87.8 93.5
4.0 4.6 1.6
42.6 43.1 42.7
45.2 56.6 62.9
61.3 67.3 66.1
5.3 4.1 4.0
3.8 3.9 1.6
3.1 2.1 1.6
4.5 5.1 0
.9 50–74.9 75–99.9 ≥ 100
473 409 443
26.0 22.5 24.4
4.7 4.6 2.3
3.6 2.2 1.6
2.7 1.2 1.4
Table 3 Association between vitamin D status in pregnancy with birth size and pregnancy loss (adjusted logistic regression analysis)
Small for gestational agea Preterm delivery (< 37 weeks)b Low birth weight (< 2500 g)c Pregnancy lossd
OR CI 95% OR CI 95% OR CI 95% OR CI 95%
T1 25OHDe
Continuous nmol/L 1.003 0.99–1.01 0.996 0.99–1.01 0.999 0.99–1.01 0.989* 0.98–1.00
< 30 (ref) 1.0 1.0 1.0 1.0
30–49.9 1.078 0.44–2.66 1.647 0.63–4.33 2.549 0.88–7.38 1.030 0.44–2.41
50–74.9 1.632 0.69–3.85 1.260 0.47–3.36 2.287 0.77–6.83 0.688 0.29–1.62
75–99-9 1.292 0.51–3.27 1.332 0.48–3.73 1.665 0.51–5.49 0.809 0.33–1.96
≥ 100 1.294 0.38–4.42 0.502 0.09–2.72 1.255 0.22–7.27 0.000f
T3 25OHDe
< 30 (ref) 1.0 1.0 1.0
30–49.9 0.771 0.34–1.75 0.302 0.08–1.14 0.071* 0.01–0.63
50–74.9 0.623 0.27–1.45 0.933 0.31–2.79 0.584 0.17–1.98
75–99-9 0.657 0.27–1.61 0.614 0.18–2.14 0.237 0.06–1.01
≥ 100 0.318* 0.11–0.90 0.446 0.11–1.76 0.215* 0.05–0.97
Δ25OHDg
Large increase (≥ 30 nmol/L) (ref) 1.0 1.0 1.0
Small increase (0–30 nmol/L) 2.564* 1.16–5.67 2.905* 1.01–8.34 3.122 0.97–10.09
Decrease (< 0 nmol/L) 3.679** 1.60–8.44 2.894 0.95–8.85 4.722* 1.37–16.28
T1 first trimester, T3 third trimester, 25OHD 25-hydroxyvitamin D
*p < 0.05 **p < 0.01
aModels include 92 (T1) and 80 (T3 and Δ25OHD) cases of small for gestational age
bModels include 77 (T1) and 43 (T3 and Δ25OHD) cases of preterm delivery
cModels include 57 (T1) and 31 (T3 and Δ25OHD) cases of low birth weight
dModels include 96 cases of pregnancy loss
eAdjusted for education, origin, season of conception and BMI at T1. Pregnancy loss models are also adjusted for gestational age at registration for antenatal care
fNo case of pregnancy loss in category
gAdjusted for education, origin, season of conception, BMI at T1 and 25OHD at T1
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increase. Neither of these results changed after adjust-
ment for tobacco use and vitamin D supplementation at
T3 or after excluding cases of preeclampsia.
Pregnancy loss
The total rate of pregnancy loss was 4.7% and the rate of
late pregnancy loss (gestational week ≥ 14 + 0) was 1.5%
(Table 1). There were nine cases of IUFD at gestational
week ≥ 22 + 0. Overall, lower T1 25OHD (as a continu-
ous but not categorical variable) was associated with
pregnancy loss (Table 3). In unadjusted analysis, T1
25OHD was associated with IUFD and women with
25OHD < 30 nmol/L at T1 had more than fourfold
higher odds of IUFD (OR = 4.52, p = 0.034).
Discussion
We found that higher vitamin D status among women
in late, but not early, pregnancy was associated with
lower probability of SGA and LBW. Vitamin D status
trajectory during pregnancy was inversely associated
with SGA, LBW and preterm delivery. Women with an
increase in 25OHD ≥30 nmol/L from T1 to T3 had thelowest odds of SGA, LBW and preterm delivery. We also
found that lower vitamin D status in early pregnancy
was related to pregnancy loss.
Previous findings from the GraviD study show lower
odds of preeclampsia among women with a large increase
(≥ 30 nmol/L) in 25OHD [3]. As SGA, LBW and preterm
delivery are related to preeclampsia; these results are
consistent with the current findings. However, excluding
preeclampsia cases from the analysis did not change the
results. Thus, preeclampsia does not seem to mediate the
associations between vitamin D status trajectory and
neonatal birth size or preterm birth. We have previously
shown that the determinants of season-corrected change in
25OHD during pregnancy include origin, sun-exposure and
dietary as well as supplementary vitamin D intake [18].
Supplements containing vitamin D were used by 43% in T1
and 39% in T3- mainly multivitamins [19]. As the results
between change in 25OHD and neonatal birth size and
preterm delivery remained after adjustment for season of
conception, origin and vitamin D supplementation, vitamin
D status trajectory can be suspected to play a role in
healthy pregnancy. Vitamin D has been shown to facilitate
the transport of nutrients across the placenta [20, 21],
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tus could also facilitate fetal development by regulating pla-
cental inflammation [23]. It is also possible that the
associations between fetal growth and maternal vitamin D
status are due to residual confounding or reverse causation.
Whether vitamin D metabolism is altered in placental dys-
function in unclear and warrants further investigation.
Our results indicates that 25OHD at T3 but not at T1 is
associated with SGA and LBW, despite better statistical
power at T1 due to more 25OHD samples and subse-
quently more cases of SGA, LBW and preterm birth. This
finding is partly consistent with previous studies where
25OHD concentrations of 25–30 nmol/L were associated
with higher probability of SGA [5–7]. The study by Burris
et al. [6] sampled women in gestational week 26–28, and
found a higher OR for SGA than the two studies that sam-
pled women in T1. This could be interpreted as support
of our finding that late rather than early pregnancy
vitamin D status is the stronger predictor of fetal growth
restriction. Our results also concur with findings by
Morley et al. that late but not early pregnancy 25OHD
was related to gestational length and neonatal birth size
[8]. Our results could also indicate that it takes time for
changes in vitamin D metabolism to manifest as changes
in circulating 25OHD. We did not see a U-shaped associ-
ation between early pregnancy vitamin D status and SGA,
as previously indicated [9]. We found the lowest odds of
SGA among women with the highest T3 25OHD concen-
tration, ≥100 nmol/L. A total of 25% of the women had
25OHD concentrations ≥100 nmol/L at T3. Sampling was
evenly distributed across the seasons and time of year
cannot explain the high proportion with high 25OHD
concentrations. Also, vitamin D supplements were used
by almost half of the women but most (88%) used multivi-
tamins containing 5–10 μg of vitamin D3. Supplementa-
tion can therefore only partly explain the large proportion
with high vitamin D status, and other likely contributors
are pregnancy associated endocrine changes and possibly
lifestyle factors.
To our knowledge, ours is one of the first studies to
find associations between vitamin D status and preg-
nancy loss. The 25OHD concentration has been shown
to have immunological effects in women with a history
of recurrent pregnancy loss [12]. Two previous studies
have investigated but not found any association between
25OHD and miscarriage [5, 13]. In those studies,
25OHD was used as a categorical variable. One earlier
study, from Denmark, found that lower vitamin D status
in early pregnancy was associated with pregnancy loss in
the first trimester [24]. We found that pregnancy loss
was associated with lower 25OHD when expressed on a
continuous but not categorical scale. As most women
with high vitamin D status were born in Sweden and
thus more likely to be familiar with the Swedish health-care system, it is possible that they registered earlier for
antenatal care and were more likely to report pregnancy
loss. However, the models were adjusted for gestational age
at registration for antenatal care. Despite few cases of IUFD
in the GraviD cohort, our results suggest that vitamin D
deficiency in early pregnancy may be linked to IUFD.
These results need confirmation, preferably by adjusted
statistical analysis as confounding can be expected, which
was not possible in our present study due to few cases.
Strengths of this study are that the GraviD cohort is repre-
sentative of the general pregnant population in terms of
origin, education, parity, BMI and tobacco use [25], which
increases the external validity of the findings. Also, gesta-
tional age at delivery was estimated by routine ultrasound,
which is considered more accurate than dating by last men-
strual period [26]. A limitation of this study is that informa-
tion on pregnancy loss, except IUFD, was self-reported. The
information on pregnancy loss is likely correct, albeit with-
out conclusive information on the time of fetal demise. Sur-
vival analysis could therefore not be performed, as time to
event data were missing. In addition, vitamin D status
among women who terminated the pregnancy was not
assessed. Data on SGA, LBW and preterm delivery were col-
lected from obstetrics charts based on standardized mea-
sures. Since there were few cases of SGA based on birth
weight alone, the definition of SGA used in this study was
based on birth weight and/or length. Among the SGA cases
defined by length only, most were close to also meeting the
SGA definition for birth weight. Therefore, the definition
used in this study is likely to be relevant. Another limitation
is that data on physical activity during pregnancy was only
available for a subset of the women and was therefore not
used.
While the GraviD study indicates an association be-
tween T3 25OHD and consequences of placental insuffi-
ciency, change in 25OHD during pregnancy might be a
stronger predictor of placental dysfunction, as it is asso-
ciated with SGA, LBW and preterm delivery. The lowest
odds of SGA and LBW are found among women with
the largest increments in 25OHD (≥ 30 nmol/L). Inter-
estingly, vitamin D status at T1- around the time the
maternal blood flow of the placenta is fully developed- is
only related to pregnancy loss.
Conclusion
In conclusion, lower early pregnancy 25OHD was associ-
ated with pregnancy loss. High vitamin D status in late, but
not early, pregnancy was associated with lower odds of
SGA and LBW. Change in 25OHD during pregnancy was
associated with SGA, LBW and preterm delivery, with the
lowest odds for women with an increment in 25OHD ≥
30 nmol/L. Both higher late pregnancy vitamin D status
and gestational vitamin D status trajectory can be
suspected to play a role in healthy pregnancy.
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